We offer Semaglutide and Tirzepatide, two potent GLP-1 receptor agonists designed for research and experimental purposes only. While they serve similar purposes, key differences exist in how they work and what you can expect from each.

Semaglutide mimics the GLP-1 hormone, enhancing insulin secretion in response to high blood sugar levels. It also slows gastric emptying and reduces appetite. Experimental objective: To study blood sugar control, significant weight loss, and decreased risk of cardiovascular events

Tirzepatide is a dual agonist miming GLP-1 and GIP (glucose-dependent insulinotropic polypeptide), enhancing insulin secretion, reducing glucagon levels, and slowing gastric emptying. Experimental objectives: To study blood sugar control, substantial weight loss compared to GLP-1 agonists alone, and improved insulin sensitivity

They could be packaged as 5 to 10mg per vail or as requested. 100% Pure Lyophilized Powder vials or a solution with 15ML spray. The minimum quantity is 500 vials/Spray. Contact us for pricing.